nodes	percent_of_prediction	percent_of_DWPC	metapath
Thiotepa—Asthenia—Captopril—systemic scleroderma	0.000862	0.000862	CcSEcCtD
Thiotepa—Dermatitis—Mometasone—systemic scleroderma	0.000862	0.000862	CcSEcCtD
Thiotepa—Decreased appetite—Leflunomide—systemic scleroderma	0.000861	0.000861	CcSEcCtD
Thiotepa—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.00086	0.00086	CcSEcCtD
Thiotepa—Confusional state—Lisinopril—systemic scleroderma	0.000858	0.000858	CcSEcCtD
Thiotepa—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000857	0.000857	CcSEcCtD
Thiotepa—Headache—Mometasone—systemic scleroderma	0.000857	0.000857	CcSEcCtD
Thiotepa—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000855	0.000855	CcSEcCtD
Thiotepa—Fatigue—Leflunomide—systemic scleroderma	0.000854	0.000854	CcSEcCtD
Thiotepa—Pruritus—Captopril—systemic scleroderma	0.00085	0.00085	CcSEcCtD
Thiotepa—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000848	0.000848	CcSEcCtD
Thiotepa—Constipation—Leflunomide—systemic scleroderma	0.000847	0.000847	CcSEcCtD
Thiotepa—Pain—Leflunomide—systemic scleroderma	0.000847	0.000847	CcSEcCtD
Thiotepa—Infection—Lisinopril—systemic scleroderma	0.000845	0.000845	CcSEcCtD
Thiotepa—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.000844	0.000844	CcSEcCtD
Thiotepa—Somnolence—Mycophenolic acid—systemic scleroderma	0.00084	0.00084	CcSEcCtD
Thiotepa—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000839	0.000839	CcSEcCtD
Thiotepa—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000833	0.000833	CcSEcCtD
Thiotepa—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000831	0.000831	CcSEcCtD
Thiotepa—Tachycardia—Lisinopril—systemic scleroderma	0.00083	0.00083	CcSEcCtD
Thiotepa—Abdominal pain—Azathioprine—systemic scleroderma	0.000829	0.000829	CcSEcCtD
Thiotepa—Body temperature increased—Azathioprine—systemic scleroderma	0.000829	0.000829	CcSEcCtD
Thiotepa—Skin disorder—Lisinopril—systemic scleroderma	0.000826	0.000826	CcSEcCtD
Thiotepa—Diarrhoea—Captopril—systemic scleroderma	0.000822	0.000822	CcSEcCtD
Thiotepa—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000821	0.000821	CcSEcCtD
Thiotepa—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000817	0.000817	CcSEcCtD
Thiotepa—Feeling abnormal—Leflunomide—systemic scleroderma	0.000816	0.000816	CcSEcCtD
Thiotepa—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000815	0.000815	CcSEcCtD
Thiotepa—Fatigue—Mycophenolic acid—systemic scleroderma	0.000814	0.000814	CcSEcCtD
Thiotepa—Nausea—Mometasone—systemic scleroderma	0.000812	0.000812	CcSEcCtD
Thiotepa—Anorexia—Lisinopril—systemic scleroderma	0.000811	0.000811	CcSEcCtD
Thiotepa—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.00081	0.00081	CcSEcCtD
Thiotepa—Weight increased—Prednisone—systemic scleroderma	0.000809	0.000809	CcSEcCtD
Thiotepa—Ataxia—Methotrexate—systemic scleroderma	0.000808	0.000808	CcSEcCtD
Thiotepa—Pain—Mycophenolic acid—systemic scleroderma	0.000808	0.000808	CcSEcCtD
Thiotepa—Constipation—Mycophenolic acid—systemic scleroderma	0.000808	0.000808	CcSEcCtD
Thiotepa—Hyperglycaemia—Prednisone—systemic scleroderma	0.000801	0.000801	CcSEcCtD
Thiotepa—Cough—Mycophenolate mofetil—systemic scleroderma	0.000797	0.000797	CcSEcCtD
Thiotepa—Dizziness—Captopril—systemic scleroderma	0.000794	0.000794	CcSEcCtD
Thiotepa—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000791	0.000791	CcSEcCtD
Thiotepa—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000788	0.000788	CcSEcCtD
Thiotepa—Urticaria—Leflunomide—systemic scleroderma	0.000786	0.000786	CcSEcCtD
Thiotepa—Body temperature increased—Leflunomide—systemic scleroderma	0.000783	0.000783	CcSEcCtD
Thiotepa—Abdominal pain—Leflunomide—systemic scleroderma	0.000783	0.000783	CcSEcCtD
Thiotepa—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000778	0.000778	CcSEcCtD
Thiotepa—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000777	0.000777	CcSEcCtD
Thiotepa—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000777	0.000777	CcSEcCtD
Thiotepa—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000775	0.000775	CcSEcCtD
Thiotepa—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000775	0.000775	CcSEcCtD
Thiotepa—Hypersensitivity—Azathioprine—systemic scleroderma	0.000772	0.000772	CcSEcCtD
Thiotepa—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000772	0.000772	CcSEcCtD
Thiotepa—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000772	0.000772	CcSEcCtD
Thiotepa—Paraesthesia—Lisinopril—systemic scleroderma	0.000764	0.000764	CcSEcCtD
Thiotepa—Vomiting—Captopril—systemic scleroderma	0.000764	0.000764	CcSEcCtD
Thiotepa—Rash—Captopril—systemic scleroderma	0.000757	0.000757	CcSEcCtD
Thiotepa—Dermatitis—Captopril—systemic scleroderma	0.000757	0.000757	CcSEcCtD
Thiotepa—Somnolence—Lisinopril—systemic scleroderma	0.000756	0.000756	CcSEcCtD
Thiotepa—Headache—Captopril—systemic scleroderma	0.000753	0.000753	CcSEcCtD
Thiotepa—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000752	0.000752	CcSEcCtD
Thiotepa—Dyspepsia—Lisinopril—systemic scleroderma	0.000749	0.000749	CcSEcCtD
Thiotepa—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000747	0.000747	CcSEcCtD
Thiotepa—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000747	0.000747	CcSEcCtD
Thiotepa—Infection—Mycophenolate mofetil—systemic scleroderma	0.00074	0.00074	CcSEcCtD
Thiotepa—Decreased appetite—Lisinopril—systemic scleroderma	0.000739	0.000739	CcSEcCtD
Thiotepa—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000734	0.000734	CcSEcCtD
Thiotepa—Fatigue—Lisinopril—systemic scleroderma	0.000733	0.000733	CcSEcCtD
Thiotepa—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000731	0.000731	CcSEcCtD
Thiotepa—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.00073	0.00073	CcSEcCtD
Thiotepa—Hypersensitivity—Leflunomide—systemic scleroderma	0.000729	0.000729	CcSEcCtD
Thiotepa—Pain—Lisinopril—systemic scleroderma	0.000727	0.000727	CcSEcCtD
Thiotepa—Constipation—Lisinopril—systemic scleroderma	0.000727	0.000727	CcSEcCtD
Thiotepa—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000727	0.000727	CcSEcCtD
Thiotepa—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000724	0.000724	CcSEcCtD
Thiotepa—Diarrhoea—Azathioprine—systemic scleroderma	0.000717	0.000717	CcSEcCtD
Thiotepa—Haemoglobin—Prednisone—systemic scleroderma	0.000715	0.000715	CcSEcCtD
Thiotepa—Nausea—Captopril—systemic scleroderma	0.000713	0.000713	CcSEcCtD
Thiotepa—Haemorrhage—Prednisone—systemic scleroderma	0.000711	0.000711	CcSEcCtD
Thiotepa—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.00071	0.00071	CcSEcCtD
Thiotepa—Asthenia—Leflunomide—systemic scleroderma	0.00071	0.00071	CcSEcCtD
Thiotepa—Hallucination—Prednisone—systemic scleroderma	0.000708	0.000708	CcSEcCtD
Thiotepa—Pancytopenia—Methotrexate—systemic scleroderma	0.000705	0.000705	CcSEcCtD
Thiotepa—Feeling abnormal—Lisinopril—systemic scleroderma	0.000701	0.000701	CcSEcCtD
Thiotepa—Pruritus—Leflunomide—systemic scleroderma	0.0007	0.0007	CcSEcCtD
Thiotepa—Connective tissue disorder—Prednisone—systemic scleroderma	0.000699	0.000699	CcSEcCtD
Thiotepa—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000696	0.000696	CcSEcCtD
Thiotepa—Dysuria—Methotrexate—systemic scleroderma	0.000694	0.000694	CcSEcCtD
Thiotepa—Dizziness—Azathioprine—systemic scleroderma	0.000693	0.000693	CcSEcCtD
Thiotepa—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000679	0.000679	CcSEcCtD
Thiotepa—Asthenia—Mycophenolic acid—systemic scleroderma	0.000678	0.000678	CcSEcCtD
Thiotepa—Diarrhoea—Leflunomide—systemic scleroderma	0.000677	0.000677	CcSEcCtD
Thiotepa—Urticaria—Lisinopril—systemic scleroderma	0.000676	0.000676	CcSEcCtD
Thiotepa—Body temperature increased—Lisinopril—systemic scleroderma	0.000672	0.000672	CcSEcCtD
Thiotepa—Abdominal pain—Lisinopril—systemic scleroderma	0.000672	0.000672	CcSEcCtD
Thiotepa—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000669	0.000669	CcSEcCtD
Thiotepa—Pruritus—Mycophenolic acid—systemic scleroderma	0.000668	0.000668	CcSEcCtD
Thiotepa—Vomiting—Azathioprine—systemic scleroderma	0.000667	0.000667	CcSEcCtD
Thiotepa—Pneumonia—Methotrexate—systemic scleroderma	0.000666	0.000666	CcSEcCtD
Thiotepa—Eye disorder—Prednisone—systemic scleroderma	0.000665	0.000665	CcSEcCtD
Thiotepa—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000663	0.000663	CcSEcCtD
Thiotepa—Infestation—Methotrexate—systemic scleroderma	0.000662	0.000662	CcSEcCtD
Thiotepa—Infestation NOS—Methotrexate—systemic scleroderma	0.000662	0.000662	CcSEcCtD
Thiotepa—Rash—Azathioprine—systemic scleroderma	0.000661	0.000661	CcSEcCtD
Thiotepa—Dermatitis—Azathioprine—systemic scleroderma	0.00066	0.00066	CcSEcCtD
Thiotepa—Headache—Azathioprine—systemic scleroderma	0.000657	0.000657	CcSEcCtD
Thiotepa—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000656	0.000656	CcSEcCtD
Thiotepa—Dizziness—Leflunomide—systemic scleroderma	0.000655	0.000655	CcSEcCtD
Thiotepa—Renal failure—Methotrexate—systemic scleroderma	0.000651	0.000651	CcSEcCtD
Thiotepa—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000648	0.000648	CcSEcCtD
Thiotepa—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000646	0.000646	CcSEcCtD
Thiotepa—Stomatitis—Methotrexate—systemic scleroderma	0.000645	0.000645	CcSEcCtD
Thiotepa—Angiopathy—Prednisone—systemic scleroderma	0.000645	0.000645	CcSEcCtD
Thiotepa—Conjunctivitis—Methotrexate—systemic scleroderma	0.000644	0.000644	CcSEcCtD
Thiotepa—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000643	0.000643	CcSEcCtD
Thiotepa—Immune system disorder—Prednisone—systemic scleroderma	0.000642	0.000642	CcSEcCtD
Thiotepa—Pain—Mycophenolate mofetil—systemic scleroderma	0.000637	0.000637	CcSEcCtD
Thiotepa—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000637	0.000637	CcSEcCtD
Thiotepa—Arrhythmia—Prednisone—systemic scleroderma	0.000635	0.000635	CcSEcCtD
Thiotepa—Haematuria—Methotrexate—systemic scleroderma	0.000631	0.000631	CcSEcCtD
Thiotepa—Vomiting—Leflunomide—systemic scleroderma	0.000629	0.000629	CcSEcCtD
Thiotepa—Alopecia—Prednisone—systemic scleroderma	0.000628	0.000628	CcSEcCtD
Thiotepa—Hypersensitivity—Lisinopril—systemic scleroderma	0.000627	0.000627	CcSEcCtD
Thiotepa—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000626	0.000626	CcSEcCtD
Thiotepa—Dizziness—Mycophenolic acid—systemic scleroderma	0.000625	0.000625	CcSEcCtD
Thiotepa—Epistaxis—Methotrexate—systemic scleroderma	0.000624	0.000624	CcSEcCtD
Thiotepa—Rash—Leflunomide—systemic scleroderma	0.000624	0.000624	CcSEcCtD
Thiotepa—Dermatitis—Leflunomide—systemic scleroderma	0.000624	0.000624	CcSEcCtD
Thiotepa—Mental disorder—Prednisone—systemic scleroderma	0.000623	0.000623	CcSEcCtD
Thiotepa—Nausea—Azathioprine—systemic scleroderma	0.000623	0.000623	CcSEcCtD
Thiotepa—Headache—Leflunomide—systemic scleroderma	0.00062	0.00062	CcSEcCtD
Thiotepa—Malnutrition—Prednisone—systemic scleroderma	0.000619	0.000619	CcSEcCtD
Thiotepa—Erythema—Prednisone—systemic scleroderma	0.000619	0.000619	CcSEcCtD
Thiotepa—Agranulocytosis—Methotrexate—systemic scleroderma	0.000618	0.000618	CcSEcCtD
Thiotepa—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000614	0.000614	CcSEcCtD
Thiotepa—Asthenia—Lisinopril—systemic scleroderma	0.00061	0.00061	CcSEcCtD
Thiotepa—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000609	0.000609	CcSEcCtD
Thiotepa—Pruritus—Lisinopril—systemic scleroderma	0.000602	0.000602	CcSEcCtD
Thiotepa—Vomiting—Mycophenolic acid—systemic scleroderma	0.0006	0.0006	CcSEcCtD
Thiotepa—Haemoglobin—Methotrexate—systemic scleroderma	0.000597	0.000597	CcSEcCtD
Thiotepa—Rash—Mycophenolic acid—systemic scleroderma	0.000595	0.000595	CcSEcCtD
Thiotepa—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000595	0.000595	CcSEcCtD
Thiotepa—Haemorrhage—Methotrexate—systemic scleroderma	0.000594	0.000594	CcSEcCtD
Thiotepa—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000592	0.000592	CcSEcCtD
Thiotepa—Headache—Mycophenolic acid—systemic scleroderma	0.000592	0.000592	CcSEcCtD
Thiotepa—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000589	0.000589	CcSEcCtD
Thiotepa—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000589	0.000589	CcSEcCtD
Thiotepa—Nausea—Leflunomide—systemic scleroderma	0.000588	0.000588	CcSEcCtD
Thiotepa—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000587	0.000587	CcSEcCtD
Thiotepa—Vision blurred—Prednisone—systemic scleroderma	0.000583	0.000583	CcSEcCtD
Thiotepa—Urethral disorder—Methotrexate—systemic scleroderma	0.000583	0.000583	CcSEcCtD
Thiotepa—Diarrhoea—Lisinopril—systemic scleroderma	0.000582	0.000582	CcSEcCtD
Thiotepa—Anaemia—Prednisone—systemic scleroderma	0.000572	0.000572	CcSEcCtD
Thiotepa—Agitation—Prednisone—systemic scleroderma	0.000569	0.000569	CcSEcCtD
Thiotepa—Dizziness—Lisinopril—systemic scleroderma	0.000563	0.000563	CcSEcCtD
Thiotepa—Nausea—Mycophenolic acid—systemic scleroderma	0.000561	0.000561	CcSEcCtD
Thiotepa—Eye disorder—Methotrexate—systemic scleroderma	0.000555	0.000555	CcSEcCtD
Thiotepa—Tinnitus—Methotrexate—systemic scleroderma	0.000554	0.000554	CcSEcCtD
Thiotepa—Cardiac disorder—Methotrexate—systemic scleroderma	0.000552	0.000552	CcSEcCtD
Thiotepa—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000549	0.000549	CcSEcCtD
Thiotepa—Vomiting—Lisinopril—systemic scleroderma	0.000541	0.000541	CcSEcCtD
Thiotepa—Angiopathy—Methotrexate—systemic scleroderma	0.000539	0.000539	CcSEcCtD
Thiotepa—Immune system disorder—Methotrexate—systemic scleroderma	0.000537	0.000537	CcSEcCtD
Thiotepa—Rash—Lisinopril—systemic scleroderma	0.000536	0.000536	CcSEcCtD
Thiotepa—Convulsion—Prednisone—systemic scleroderma	0.000536	0.000536	CcSEcCtD
Thiotepa—Dermatitis—Lisinopril—systemic scleroderma	0.000536	0.000536	CcSEcCtD
Thiotepa—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000536	0.000536	CcSEcCtD
Thiotepa—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000535	0.000535	CcSEcCtD
Thiotepa—Hypertension—Prednisone—systemic scleroderma	0.000534	0.000534	CcSEcCtD
Thiotepa—Chills—Methotrexate—systemic scleroderma	0.000533	0.000533	CcSEcCtD
Thiotepa—Headache—Lisinopril—systemic scleroderma	0.000533	0.000533	CcSEcCtD
Thiotepa—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000527	0.000527	CcSEcCtD
Thiotepa—Arthralgia—Prednisone—systemic scleroderma	0.000527	0.000527	CcSEcCtD
Thiotepa—Myalgia—Prednisone—systemic scleroderma	0.000527	0.000527	CcSEcCtD
Thiotepa—Anxiety—Prednisone—systemic scleroderma	0.000525	0.000525	CcSEcCtD
Thiotepa—Alopecia—Methotrexate—systemic scleroderma	0.000525	0.000525	CcSEcCtD
Thiotepa—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000523	0.000523	CcSEcCtD
Thiotepa—Mental disorder—Methotrexate—systemic scleroderma	0.000521	0.000521	CcSEcCtD
Thiotepa—Malnutrition—Methotrexate—systemic scleroderma	0.000517	0.000517	CcSEcCtD
Thiotepa—Erythema—Methotrexate—systemic scleroderma	0.000517	0.000517	CcSEcCtD
Thiotepa—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.00051	0.00051	CcSEcCtD
Thiotepa—Nausea—Lisinopril—systemic scleroderma	0.000505	0.000505	CcSEcCtD
Thiotepa—Infection—Prednisone—systemic scleroderma	0.000502	0.000502	CcSEcCtD
Thiotepa—Back pain—Methotrexate—systemic scleroderma	0.0005	0.0005	CcSEcCtD
Thiotepa—Nervous system disorder—Prednisone—systemic scleroderma	0.000495	0.000495	CcSEcCtD
Thiotepa—Tachycardia—Prednisone—systemic scleroderma	0.000493	0.000493	CcSEcCtD
Thiotepa—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000493	0.000493	CcSEcCtD
Thiotepa—Skin disorder—Prednisone—systemic scleroderma	0.000491	0.000491	CcSEcCtD
Thiotepa—Vision blurred—Methotrexate—systemic scleroderma	0.000488	0.000488	CcSEcCtD
Thiotepa—Anorexia—Prednisone—systemic scleroderma	0.000482	0.000482	CcSEcCtD
Thiotepa—Anaemia—Methotrexate—systemic scleroderma	0.000478	0.000478	CcSEcCtD
Thiotepa—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000474	0.000474	CcSEcCtD
Thiotepa—Rash—Mycophenolate mofetil—systemic scleroderma	0.00047	0.00047	CcSEcCtD
Thiotepa—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.00047	0.00047	CcSEcCtD
Thiotepa—Headache—Mycophenolate mofetil—systemic scleroderma	0.000467	0.000467	CcSEcCtD
Thiotepa—Leukopenia—Methotrexate—systemic scleroderma	0.000463	0.000463	CcSEcCtD
Thiotepa—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.00046	0.00046	CcSEcCtD
Thiotepa—Paraesthesia—Prednisone—systemic scleroderma	0.000454	0.000454	CcSEcCtD
Thiotepa—Cough—Methotrexate—systemic scleroderma	0.000451	0.000451	CcSEcCtD
Thiotepa—Convulsion—Methotrexate—systemic scleroderma	0.000448	0.000448	CcSEcCtD
Thiotepa—Dyspepsia—Prednisone—systemic scleroderma	0.000445	0.000445	CcSEcCtD
Thiotepa—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000443	0.000443	CcSEcCtD
Thiotepa—Myalgia—Methotrexate—systemic scleroderma	0.00044	0.00044	CcSEcCtD
Thiotepa—Arthralgia—Methotrexate—systemic scleroderma	0.00044	0.00044	CcSEcCtD
Thiotepa—Decreased appetite—Prednisone—systemic scleroderma	0.000439	0.000439	CcSEcCtD
Thiotepa—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000437	0.000437	CcSEcCtD
Thiotepa—Fatigue—Prednisone—systemic scleroderma	0.000436	0.000436	CcSEcCtD
Thiotepa—Constipation—Prednisone—systemic scleroderma	0.000432	0.000432	CcSEcCtD
Thiotepa—Confusional state—Methotrexate—systemic scleroderma	0.000426	0.000426	CcSEcCtD
Thiotepa—Infection—Methotrexate—systemic scleroderma	0.000419	0.000419	CcSEcCtD
Thiotepa—Feeling abnormal—Prednisone—systemic scleroderma	0.000416	0.000416	CcSEcCtD
Thiotepa—Nervous system disorder—Methotrexate—systemic scleroderma	0.000414	0.000414	CcSEcCtD
Thiotepa—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000413	0.000413	CcSEcCtD
Thiotepa—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000413	0.000413	CcSEcCtD
Thiotepa—Skin disorder—Methotrexate—systemic scleroderma	0.00041	0.00041	CcSEcCtD
Thiotepa—Anorexia—Methotrexate—systemic scleroderma	0.000402	0.000402	CcSEcCtD
Thiotepa—Urticaria—Prednisone—systemic scleroderma	0.000401	0.000401	CcSEcCtD
Thiotepa—Body temperature increased—Prednisone—systemic scleroderma	0.000399	0.000399	CcSEcCtD
Thiotepa—Abdominal pain—Prednisone—systemic scleroderma	0.000399	0.000399	CcSEcCtD
Thiotepa—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000385	0.000385	CcSEcCtD
Thiotepa—Paraesthesia—Methotrexate—systemic scleroderma	0.000379	0.000379	CcSEcCtD
Thiotepa—Somnolence—Methotrexate—systemic scleroderma	0.000375	0.000375	CcSEcCtD
Thiotepa—Hypersensitivity—Prednisone—systemic scleroderma	0.000372	0.000372	CcSEcCtD
Thiotepa—Dyspepsia—Methotrexate—systemic scleroderma	0.000372	0.000372	CcSEcCtD
Thiotepa—Decreased appetite—Methotrexate—systemic scleroderma	0.000367	0.000367	CcSEcCtD
Thiotepa—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000365	0.000365	CcSEcCtD
Thiotepa—Fatigue—Methotrexate—systemic scleroderma	0.000364	0.000364	CcSEcCtD
Thiotepa—Asthenia—Prednisone—systemic scleroderma	0.000362	0.000362	CcSEcCtD
Thiotepa—Pain—Methotrexate—systemic scleroderma	0.000361	0.000361	CcSEcCtD
Thiotepa—Pruritus—Prednisone—systemic scleroderma	0.000357	0.000357	CcSEcCtD
Thiotepa—Feeling abnormal—Methotrexate—systemic scleroderma	0.000348	0.000348	CcSEcCtD
Thiotepa—Diarrhoea—Prednisone—systemic scleroderma	0.000346	0.000346	CcSEcCtD
Thiotepa—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000345	0.000345	CcSEcCtD
Thiotepa—Urticaria—Methotrexate—systemic scleroderma	0.000335	0.000335	CcSEcCtD
Thiotepa—Dizziness—Prednisone—systemic scleroderma	0.000334	0.000334	CcSEcCtD
Thiotepa—Abdominal pain—Methotrexate—systemic scleroderma	0.000334	0.000334	CcSEcCtD
Thiotepa—Body temperature increased—Methotrexate—systemic scleroderma	0.000334	0.000334	CcSEcCtD
Thiotepa—Vomiting—Prednisone—systemic scleroderma	0.000321	0.000321	CcSEcCtD
Thiotepa—Rash—Prednisone—systemic scleroderma	0.000319	0.000319	CcSEcCtD
Thiotepa—Dermatitis—Prednisone—systemic scleroderma	0.000318	0.000318	CcSEcCtD
Thiotepa—Headache—Prednisone—systemic scleroderma	0.000317	0.000317	CcSEcCtD
Thiotepa—Hypersensitivity—Methotrexate—systemic scleroderma	0.000311	0.000311	CcSEcCtD
Thiotepa—Asthenia—Methotrexate—systemic scleroderma	0.000303	0.000303	CcSEcCtD
Thiotepa—Nausea—Prednisone—systemic scleroderma	0.0003	0.0003	CcSEcCtD
Thiotepa—Pruritus—Methotrexate—systemic scleroderma	0.000299	0.000299	CcSEcCtD
Thiotepa—Diarrhoea—Methotrexate—systemic scleroderma	0.000289	0.000289	CcSEcCtD
Thiotepa—Dizziness—Methotrexate—systemic scleroderma	0.000279	0.000279	CcSEcCtD
Thiotepa—Vomiting—Methotrexate—systemic scleroderma	0.000268	0.000268	CcSEcCtD
Thiotepa—Rash—Methotrexate—systemic scleroderma	0.000266	0.000266	CcSEcCtD
Thiotepa—Dermatitis—Methotrexate—systemic scleroderma	0.000266	0.000266	CcSEcCtD
Thiotepa—Headache—Methotrexate—systemic scleroderma	0.000265	0.000265	CcSEcCtD
Thiotepa—Nausea—Methotrexate—systemic scleroderma	0.000251	0.000251	CcSEcCtD
